{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:48:11Z","timestamp":1769165291771,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T00:00:00Z","timestamp":1405641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s13730-014-0135-0","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T05:33:54Z","timestamp":1405575234000},"page":"31-37","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma"],"prefix":"10.1007","volume":"4","author":[{"given":"Tomohiro","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Tsuruoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,18]]},"reference":[{"key":"135_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0272-6386(12)70160-9","volume":"22","author":"DM Burstein","year":"1993","unstructured":"Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5\u201310.","journal-title":"Am J Kidney Dis"},{"key":"135_CR2","first-page":"195","volume":"46","author":"M W\u0105growska-Danilewicz","year":"1995","unstructured":"W\u0105growska-Danilewicz M, Danilewicz M. Glomerulonephritis associated with malignant disease of non-renal origin. A report of three cases and a review of the literature. Pol J Pathol. 1995;46:195\u20138.","journal-title":"Pol J Pathol"},{"key":"135_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000181984","volume":"26","author":"JH Ross","year":"1980","unstructured":"Ross JH, McGinty F, Brewer DG. Penicillamine nephropathy. Nephron. 1980;26:184\u20136.","journal-title":"Nephron"},{"key":"135_CR4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/ajkd.2002.31987","volume":"39","author":"K Nagahama","year":"2002","unstructured":"Nagahama K, Matsushita H, Hara M, et al. Bucillamine induces membranous glomerulonephritis. Am J Kidney Dis. 2002;39:706\u201312.","journal-title":"Am J Kidney Dis"},{"key":"135_CR5","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.1983.03340170069032","volume":"250","author":"BC Sturgill","year":"1983","unstructured":"Sturgill BC, Shearlock KT. Membranous glomerulopathy and nephrotic syndrome after captopril therapy. JAMA. 1983;250:2343\u20135.","journal-title":"JAMA"},{"key":"135_CR6","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1681\/ASN.2005010028","volume":"16","author":"D Cattran","year":"2005","unstructured":"Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005;16:1188\u201394.","journal-title":"J Am Soc Nephrol"},{"key":"135_CR7","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1523-1755.2004.00518.x","volume":"65","author":"H Shiiki","year":"2004","unstructured":"Shiiki H, Saito T, Nishitani Y, et al. Prognosis and risk factors for idiopathic membranous nephropathy with nephrotic syndrome in Japan. Kidney Int. 2004;65:1400\u20137.","journal-title":"Kidney Int"},{"key":"135_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"135_CR9","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ki.2012.209","volume":"82","author":"E Hoxha","year":"2012","unstructured":"Hoxha E, Knei\u00dfler U, Stege G, et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int. 2012;82:797\u2013804.","journal-title":"Kidney Int"},{"key":"135_CR10","first-page":"57","volume":"58","author":"T Doi","year":"1984","unstructured":"Doi T, Mayumi M, Kanatsu K, et al. Distribution of IgG subclasses in membranous nephropathy. Clin Exp Immunol. 1984;58:57\u201362.","journal-title":"Clin Exp Immunol"},{"key":"135_CR11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1523-1755.2005.00415.x","volume":"68","author":"A Kuroki","year":"2005","unstructured":"Kuroki A, Iyoda M, Shibata T, et al. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005;68:302\u201310.","journal-title":"Kidney Int"},{"key":"135_CR12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transpl. 2004;19:574\u20139.","journal-title":"Nephrol Dial Transpl"},{"key":"135_CR13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0140-6736(97)04122-6","volume":"351","author":"DB Oliveira","year":"1998","unstructured":"Oliveira DB. Membranous nephropathy: an IgG4-mediated disease. Lancet. 1998;351:670\u20131.","journal-title":"Lancet"},{"key":"135_CR14","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","volume":"27","author":"Z Qu","year":"2012","unstructured":"Qu Z, Liu G, Li J, et al. Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy. Nephrol Dial Transpl. 2012;27:1931\u20137.","journal-title":"Nephrol Dial Transpl"},{"key":"135_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrneph.2010.171","volume":"7","author":"YH Lien","year":"2011","unstructured":"Lien YH, Lai LW. Pathogenesis, diagnosis and management of paraneoplastic glomerulonephritis. Nat Rev Nephrol. 2011;7:85\u201395.","journal-title":"Nat Rev Nephrol"},{"key":"135_CR16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ki.2012.484","volume":"84","author":"KD Jhaveri","year":"2013","unstructured":"Jhaveri KD, Shah HH, Calderon K, et al. Glomerular diseases seen with cancer and chemotherapy: a narrative review. Kidney Int. 2013;84:34\u201344.","journal-title":"Kidney Int"},{"key":"135_CR17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s10157-008-0066-1","volume":"12","author":"K Masutani","year":"2008","unstructured":"Masutani K, Fujisaki K, Maeda H, et al. Tubulointerstitial nephritis and IgA nephropathy in a patient with advanced lung cancer treated with long-term gefitinib. Clin Exp Nephrol. 2008;12:398\u2013402.","journal-title":"Clin Exp Nephrol"},{"key":"135_CR18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/annonc\/mdh011","volume":"15","author":"G Selvaggi","year":"2004","unstructured":"Selvaggi G, Novello S, Torri V, et al. Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer. Ann Oncol. 2004;15:28\u201332.","journal-title":"Ann Oncol"},{"key":"135_CR19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/jjco\/hyp141","volume":"40","author":"H Mori","year":"2010","unstructured":"Mori H, Hhno Y, Ito F, et al. Massive hematuria from the bilateral upper urinary tract in a patient treated for advanced lung cancer with gefitinib. Jpn J Clin Oncol. 2010;40:263\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"135_CR20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-005-2581-0","volume":"184","author":"HL Wan","year":"2006","unstructured":"Wan HL, Yao NS. Acute renal failure associated with gefitinib therapy. Lung. 2006;184:249\u201350.","journal-title":"Lung"},{"key":"135_CR21","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1200\/JCO.2004.09.064","volume":"22","author":"R Kumasaka","year":"2004","unstructured":"Kumasaka R, Nakamura N, Shirato K, et al. Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy. J Clin Oncol. 2004;22:2504\u20135.","journal-title":"J Clin Oncol"},{"key":"135_CR22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1523-1755.1999.00548.x","volume":"56","author":"PM Ronco","year":"1999","unstructured":"Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999;56:355\u201377.","journal-title":"Kidney Int"},{"key":"135_CR23","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0270-9295(03)00055-X","volume":"23","author":"JA Jefferson","year":"2003","unstructured":"Jefferson JA, Couser WG. Therapy of membranous nephropathy associated with malignancy and secondary causes. Semin Nephrol. 2003;23:400\u20135.","journal-title":"Semin Nephrol"},{"key":"135_CR24","first-page":"154","volume":"50","author":"M Nakano","year":"1998","unstructured":"Nakano M, Ueno M, Nishi S, et al. Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis. Clin Nephrol. 1998;50:154\u201360.","journal-title":"Clin Nephrol"},{"key":"135_CR25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1078155212459668","volume":"19","author":"C Ito","year":"2013","unstructured":"Ito C, Fujii H, Ogura M, et al. Cetuximab-induced nephrotic syndrome in a case of metastatic rectal cancer. J Oncol Pharm Pract. 2013;19:265\u20138.","journal-title":"J Oncol Pharm Pract"},{"key":"135_CR26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","volume":"358","author":"V Eremina","year":"2008","unstructured":"Eremina V, Jefferson JA, Kowalewska J, et al. VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129\u201336.","journal-title":"N Engl J Med"},{"key":"135_CR27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","volume":"14","author":"SR Hayman","year":"2012","unstructured":"Hayman SR, Leung N, Grande JP, et al. VEGF inhibition, hypertension, and renal toxicity. Curr Oncol Rep. 2012;14:285\u201394.","journal-title":"Curr Oncol Rep"},{"key":"135_CR28","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1200\/JCO.2010.34.3368","volume":"29","author":"T Kijima","year":"2011","unstructured":"Kijima T, Shimizu T, Nonen S, et al. Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity: difference in metabolism as a possible mechanism. J Clin Oncol. 2011;29:588\u201390.","journal-title":"J Clin Oncol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0135-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-014-0135-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0135-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:44:58Z","timestamp":1559493898000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-014-0135-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,18]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["135"],"URL":"https:\/\/doi.org\/10.1007\/s13730-014-0135-0","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,18]]}}}